BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 17089236)

  • 1. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antioxidative features of ambroxol--usefulness in COPD].
    Nowak D
    Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
    [No Abstract]   [Full Text] [Related]  

  • 3. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
    Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
    Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm-dependent airway infections: a role for ambroxol?
    Cataldi M; Sblendorio V; Leo A; Piazza O
    Pulm Pharmacol Ther; 2014 Aug; 28(2):98-108. PubMed ID: 24252805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surfactant and ambroxol in the therapy of idiopathic respiratory syndrome in newborn infants].
    Carrera G; Liberatore A; Riboni G; Clementi M
    Minerva Pediatr; 1991 Nov; 43(11):723-30. PubMed ID: 1791799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antioxidative and inflammation inhibiting properties of ambroxol].
    Winsel K
    Pneumologie; 1992 Sep; 46(9):461-75. PubMed ID: 1438126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of ambroxol given prenatally and postnatally on gas exchange in the newborn with respiratory distress syndrome].
    Sackey S; Gadzinowski J; Szymankiewicz M; Breborowicz GH; Rudnicki J; Patalan J; Rózewicki K
    Ginekol Pol; 1995 Jul; 66(7):409-12. PubMed ID: 8655006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Ambroxol on bleomycin-induced changes in phospholipid composition of rat lung surfactant.
    Stettner S; Ledwozyw A
    Acta Physiol Hung; 1995; 83(2):181-7. PubMed ID: 8588505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bronchial mucus modifiers, antioxidants and antiproteases].
    Polu JM; Chabot F; Wallaert B
    Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiinflammatory properties of ambroxol.
    Beeh KM; Beier J; Esperester A; Paul LD
    Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Klin Med (Mosk); 1988 Mar; 66(3):45-7. PubMed ID: 3392922
    [No Abstract]   [Full Text] [Related]  

  • 15. Talniflumate (Genaera).
    Knight D
    Curr Opin Investig Drugs; 2004 May; 5(5):557-62. PubMed ID: 15202731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolytics and antioxidant activity.
    Strapková A; Nosál'ová G; Franová S
    Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of ambroxol--review and new results.
    Disse BG
    Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical research on high-dosage ambroxol hydrochloride associated with ulinastatin in improvement of lung tissue injury of patients with paraquat poisoning].
    Wang WS; Guan JY; Lu QL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Jan; 28(1):58-60. PubMed ID: 20426988
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of mucolytics in wet cough.
    Dhar R
    J Assoc Physicians India; 2013 May; 61(5 Suppl):23-7. PubMed ID: 24490447
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances with surfactant.
    Turell DC
    Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.